Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2004
Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983-2001Joke Snoeck, Kristel Van Laethem, Philippe Hermans, et al.
Human Vaccines & Immunotherapeutics|July 3, 2020
Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groupsLise Boey, Eline Bosmans, Liane Braz Ferreira, et al.
Antiviral Therapy|June 26, 2008
World Health Organization/HIVResNet Drug Resistance Laboratory StrategySilvia Bertagnolio, Inge Derdelinckx, Monica Parker, et al.
Vaccines|January 7, 2021
Seroprevalence of Antibodies against Diphtheria, Tetanus and Pertussis in Adult At-Risk PatientsLise Boey, Eline Bosmans, Liane Braz Ferreira, et al.
FEMS Immunology and Medical Microbiology|November 20, 2003
Performance of the VERSANT HIV-1 resistance assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypesInge Derdelinckx, Kristel Van Laethem, Bart Maes, et al.
Frontiers in Immunology|May 30, 2017
Fifth Percentile Cutoff Values for Antipneumococcal Polysaccharide and Anti-Salmonella typhi Vi IgG Describe a Normal Polysaccharide ResponseHeidi Schaballie, Barbara Bosch, Rik Schrijvers, et al.
Antiviral Chemistry & Chemotherapy|December 24, 2002
A combination of poor adherence and a low baseline susceptibility score is highly predictive for HAART failureKristien Van Vaerenbergh, Sabina De Geest, Inge Derdelinckx, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 30, 2004
Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring systemRainer Ziermann, Linda Celis, Inge Derdelinckx, et al.
Plos One|July 9, 2014
Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemicAndrea-Clemencia Pineda-Peña, Yoeri Schrooten, Lore Vinken, et al.
AIDS Research and Human Retroviruses|March 11, 2008
Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006Jurgen Vercauteren, Inge Derdelinckx, André Sasse, et al.
Pageof 4